Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Prevalence and impact of manic traits in depressed patients initiating interferon therapy for chronic hepatitis C infection.

Lim C, Olson J, Zaman A, Phelps J, Ingram KD.

J Clin Gastroenterol. 2010 Aug;44(7):e141-6. doi: 10.1097/MCG.0b013e3181dc24f8.

PMID:
20495465
2.

Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.

Constant A, Castera L, Dantzer R, Couzigou P, de Ledinghen V, Demotes-Mainard J, Henry C.

J Clin Psychiatry. 2005 Aug;66(8):1050-7.

PMID:
16086622
3.

Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.

Dell'Osso L, Pini S, Maggi L, Rucci P, Del Debbio A, Carlini M, Baldini A, Ferrari G, Manca E, Beverini E, Amore M, Scarallo V, Semeraro Q, Brunetto M, Bonino F, Maj M.

J Psychosom Res. 2007 Mar;62(3):349-55.

PMID:
17324686
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.
6.

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.

Maddock C, Baita A, Orrù MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM.

J Psychopharmacol. 2004 Mar;18(1):41-6.

PMID:
15107183
7.

Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.

Kamat SA, Rajagopalan K, Pethick N, Willey V, Bullano M, Hassan M.

J Manag Care Pharm. 2008 Sep;14(7):631-42.

PMID:
18774873
8.

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F.

Aliment Pharmacol Ther. 2002 Sep;16(9):1633-9.

9.

Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.

Bargiggia S, Thorburn D, Anderloni A, Ardizzone S, Giorgi A, Bianchi Porro G, Parente F.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):209-15.

10.

[Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].

Norton J, de Roquefeuil G, David M, Boulenger JP, Ritchie K, Mann A.

Encephale. 2009 Dec;35(6):560-9. doi: 10.1016/j.encep.2008.06.018. Epub . French.

PMID:
20004287
11.

Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population.

Ho SB, Nguyen H, Tetrick LL, Opitz GA, Basara ML, Dieperink E.

Am J Gastroenterol. 2001 Jan;96(1):157-64.

PMID:
11197246
12.

Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

Loftis JM, Socherman RE, Howell CD, Whitehead AJ, Hill JA, Dominitz JA, Hauser P.

Neurosci Lett. 2004 Jul 22;365(2):87-91.

PMID:
15245784
13.

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.

Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K.

Hepatology. 2003 Feb;37(2):443-51.

PMID:
12540795
14.
15.

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.

Aliment Pharmacol Ther. 2002 Jun;16(6):1091-9.

16.

[Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C].

Hwang SY, Lee HJ, Park KT, Kim KY, Lee SM, Park CW, Kim TO, Kim GH, Heo J, Kang DH, Song GA, Cho M, Cho BM.

Korean J Gastroenterol. 2007 Mar;49(3):166-72. Korean.

17.
18.

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.

Zylberberg H, Benhamou Y, Lagneaux JL, Landau A, Chaix ML, Fontaine H, Bochet M, Poynard T, Katlama C, Pialoux G, Bréchot C, Pol S.

Gut. 2000 Nov;47(5):694-7.

19.

A case of interferon alpha-induced manic psychosis in chronic hepatitis C.

Kanno A, Yamada M, Abe M, Okamoto Y.

Tohoku J Exp Med. 1999 Jan;187(1):79-82.

20.

Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.

Schmidt F, Janssen G, Martin G, Lorenz R, Loeschke K, Soyka M, Folwaczny C, Schaefer M.

Aliment Pharmacol Ther. 2009 Nov 15;30(10):1049-59. doi: 10.1111/j.1365-2036.2009.04123.x. Epub 2009 Aug 18.

Items per page

Supplemental Content

Write to the Help Desk